7.28
Noncompartmental Analysis: Mean Transit, Absorption and Dissolution Time
When drugs are administered extravascularly, a comprehensive evaluation through noncompartmental analysis becomes imperative. This analytical approach…
When drugs are administered extravascularly, various parameters are considered for noncompartmental analysis.
The mean transit time, MTT, is the total time for drug molecules to transit through the body and is the ratio of area under the moment curve to area under the concentration-time curve.
It reflects the drug's mean absorption time to reach the systemic circulation, MAT, and mean residence time in the systemic circulation, MRT.
The administration route influences mean absorption and transit times while mean residence time remains constant.
In the case of oral immediate-release-type tablets or capsules, mean dissolution time, MDT comes into play. It reflects the time for the drug to dissolve in vivo.
MDT is the difference between the mean transit time for a solution and the mean transit time for an immediate-release solid drug product.
View the full transcript and gain access to JoVE Core videos
Q1: What is mean transit time and how is it calculated in noncompartmental analysis?
Mean transit time (MTT) represents the total duration for drug molecules to transit through the body following extravascular administration. It is calculated as the ratio of the area under the moment curve to the area under the concentration-time curve. MTT provides insights into how long a drug remains in the body and reflects both the drug's mean absorption time and mean residence time in systemic circulation.
Q2: How do mean absorption time and mean residence time relate to mean transit time?
Mean transit time (MTT) is composed of two key components: mean absorption time (MAT), which is the time for drug to reach systemic circulation, and mean residence time (MRT), which is the time the drug spends in systemic circulation. Together, MAT and MRT determine the overall MTT. Notably, mean residence time remains constant regardless of the administration route, while MAT varies based on the route used.
Q3: What is mean dissolution time and why does it matter for oral drug products?
Mean dissolution time (MDT) reflects the time required for an oral drug to dissolve in vivo. It is particularly relevant for immediate-release tablets and capsules. MDT is calculated as the difference between the mean transit time for a solution and the mean transit time for an immediate-release solid drug product, providing valuable information about the drug's dissolution characteristics within the body.
Q4: How does extended-release formulation affect mean dissolution time compared to immediate-release products?
Extended-release (ER) formulations have significantly longer mean dissolution times than immediate-release (IR) products because their release is controlled by mechanisms such as matrix systems, coatings, or osmotic pumps. These mechanisms deliberately extend the dissolution process, resulting in a higher MDT. This controlled release pattern contrasts with immediate-release formulations, which exhibit predictable, rapid dissolution patterns.
Q5: Why does administration route influence mean absorption and transit times?
The administration route affects how quickly and completely a drug reaches systemic circulation, thereby influencing mean absorption time (MAT) and mean transit time (MTT). Different routes—such as oral, intramuscular, or subcutaneous—present varying barriers to absorption and different pathways through the body. However, mean residence time in systemic circulation remains constant regardless of route, as it depends on the drug's elimination characteristics.
Q6: What parameters are essential for noncompartmental analysis of extravascularly administered drugs?
Noncompartmental analysis of extravascularly administered drugs requires evaluation of mean transit time (MTT), mean absorption time (MAT), mean residence time (MRT), and for oral solid formulations, mean dissolution time (MDT). These parameters collectively describe the drug's transit, absorption, residence, and dissolution processes. Understanding these parameters enables informed decisions regarding dosing regimens, therapeutic efficacy, and potential drug interactions.
Q7: How is mean dissolution time determined for immediate-release solid drug products?
Mean dissolution time for immediate-release products is determined by calculating the difference between the mean transit time for a solution formulation and the mean transit time for the immediate-release solid drug product. This calculation isolates the dissolution component from the overall transit process. Since immediate-release products exhibit predictable dissolution patterns, this distinction provides a straightforward indication of the drug's in vivo dissolution characteristics.